Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Active
Last updated: June 5, 2026
Plan A Male Contraceptive System

Vasalgel

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Vas Deferens
  • Intended Duration: Long-Acting
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): Parsemus Foundation, NEXT Life Sciences
Active
Last updated: June 5, 2026
NLS-133 Non-Hormonal Oral Contraceptive
  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Oral
  • Intended Duration: Pericoital
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): NEXT Life Sciences
Active
Last updated: June 5, 2026
Silodosin
  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Oral
  • Intended Duration: Pericoital
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): TSS Shripad Hegde Kadave Institute of Medical Sciences, Benha University, Recep Tayyip Erdogan University
Active
Last updated: June 5, 2026
Ovaprene
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Multiple
  • Intended Duration: Short-Acting
  • Development Stage: Phase III
  • Developer(s)/Researcher(s): Dare BioScience Inc.
Active
Last updated: June 5, 2026
EPPIN Inhibitors

EP055

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Oral
  • Intended Duration: Pericoital
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Eppin Pharma, Inc., University of North Carolina, São Paulo State University, Washington University, Queensland University
Active
Last updated: June 5, 2026
YCT-529 Oral Male Contraceptive

RARa Inhibitors, ER-50891

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Oral
  • Intended Duration: Short-Acting
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): YourChoice Therapeutics, University of Minnesota
Active
Last updated: June 5, 2026
NES + Testosterone Gel

NES/T

  • User: Male
  • Hormonal: Hormonal
  • Delivery Type: Transdermal
  • Intended Duration: Short-Acting
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): Population Council, LA Biomedical Research Institute, University of Washington, Health Decisions, NICHD, Contraline
Active
Last updated: June 5, 2026
Biodegradable Intrauterine Device

ZnCa IUD, ZnSr IUD

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Intrauterine
  • Intended Duration: Not Yet Determined
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Jilin University, Liaoning Academy of Materials, Peking University
Active
Last updated: May 27, 2026
Artificial Cryptorchidism

Andro-Switch Ring, Cobalt Boxer

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Testicular
  • Intended Duration: Short-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Centre Hospitalier Universitaire de Toulouse, Thoreme, Entrelac, Cobalt Contraception
Active
Last updated: May 27, 2026
Thermal Male Underwear

Spermapause

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Testicular
  • Intended Duration: Short-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Jemaya Innovations